申请人:TAISHO PHARMACEUTICAL CO., LTD
公开号:EP1820504A1
公开(公告)日:2007-08-22
An imine compound represented by the formula:
wherein A represents a heterocyclic group; R1, R2, an R3 each represent a hydrogen atom, a halogen atom, a C1-10 alkyl group optionally substituted with an aryl group(s) substituted with a halogen atom (s), a C3-10 cycloalkyl group, a C1-6 haloalkyl group, a C1-10 alkoxy group, etc.; R4 represents an optionally substituted C1-10 alkyl, C2-6 alkenyl, or aryl group; R5 represents a hydrogen atom, a C1-10 alkoxy group, a C1-6 haloalkyl group, an optionally substituted C1-10 alkyl or C2-6 alkenyl group, an optionally substituted aryl or heterocyclic group, etc.; W represents -CO-, -CO-CO-, -CO-NH-, -CS-NH-, or -SO2-,
or a cannabinoid-receptor agonist comprising said imine compound as an active ingredient.
The imine compound of the present invention has a cannabinoid-receptor agonist effect, and is useful as a therapeutic or prophylactic drug for pains and autoimmune diseases.
本发明的亚胺化合物的化学式为:其中A代表杂环基团;R1、R2和R3分别代表氢原子、卤原子、一个C1-10烷基基团,该基团可以选择性地被芳基基团取代,该芳基基团被卤原子取代,一个C3-10环烷基基团,一个C1-6卤代烷基基团,一个C1-10烷氧基基团等;R4代表一个可以选择性取代的C1-10烷基、C2-6烯基或芳基基团;R5代表一个氢原子、一个C1-10烷氧基基团、一个C1-6卤代烷基基团、一个可以选择性取代的C1-10烷基或C2-6烯基基团、一个可以选择性取代的芳基或杂环基团等;W代表-CO-、-CO-CO-、-CO-NH-、-CS-NH-或-SO2-,或者一种包含上述亚胺化合物作为活性成分的大麻素受体激动剂。本发明的亚胺化合物具有大麻素受体激动剂效应,并且可用作治疗或预防疼痛和自身免疫疾病的药物。